A new injectable drug, MBP 8298, could help. It's similar to an allergy shot. Patients who have M-S lose the protective layer, myelin, which allows the central nervous system to send messages to the body. This twice-a-year injection introduces a protein that helps the immune system build tolerance to the disease. "What we hope is that infusion of this small peptide, or small protein, will prevent or stop or at least, hopefully, slow this progressive, downhill course that these patients have," Cohen said. Cohen says this drug won't offer patients a cure, but it could give them something almost as good. "People can live a semi-normal, almost normal life, and plan for the future and know what to expect." "To know that this drug could start to slow down the process, that gives me somewhat of an encouragement that, yes, I can take care of myself," Gregory said, hopefully. Trials of the drug are currently taking place across the U.S. and Canada. Dr. Cohen says it could be several years before the drug is widely available, but he says current tests have been very successful.
Enrollment Begins For Study Of MBP8298 In Secondary-Progressive Multiple Sclerosis
Started at the end of summer 2007 so It will be awhile before we'll know if this might be an option for relapsing MS.